SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-002831
Filing Date
2017-04-24
Accepted
2017-04-24 09:10:35
Documents
9
Period of Report
2017-06-07
Effectiveness Date
2017-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2231861zdef14a.htm DEF 14A 284419
2 G700527.JPG g700527.jpg GRAPHIC 4723
3 G343314.JPG g343314.jpg GRAPHIC 602
4 G713595.JPG g713595.jpg GRAPHIC 625
5 G171131.JPG g171131.jpg GRAPHIC 3949
6 G198114.JPG g198114.jpg GRAPHIC 3272
7 G603824.JPG g603824.jpg GRAPHIC 3928
8 G24012BGI001.GIF g24012bgi001.gif GRAPHIC 69846
9 G24012BII001.GIF g24012bii001.gif GRAPHIC 50892
  Complete submission text file 0001047469-17-002831.txt   476515
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37526 | Film No.: 17777344
SIC: 2834 Pharmaceutical Preparations